Chinese Pharmaceutical Industry Competes for Vaccine Market Share
China’s National Medical Products Administration has announced that two Chinese pharmaceutical companies, Walvax Biotechnology and Innovax, have been approved to start selling their own version of drugs previously available only through global pharmaceutical giants Pfizer, Merck and GlaxoSmithKline.1 Cecolin, developed by Innovax, will compete in the Human Papilloma Virus (HPV) arena against Merck’s Gardasil and […]
Tamiflu on Track to Be an Over-The-Counter Drug
In July 2019, drug and French vaccine manufacturer Sanofi signed a deal with Roche Pharmaceuticals to obtain exclusive over-the-counter (OTC) rights for Tamiflu (oseltamivir), an antiviral drug licensed for the treatment of influenza infections. Genentech, a member of the Roche Group, currently sells Tamiflu in the United States only for prescription use.1 Tamiflu is a […]
Vaccine Market Valued at $93 Billion by 2026
A recent report by Fortune Business Insights projects the value of the world market for vaccines to reach $93.08 billion by 2026, with a Compound Annual Growth Rate (CAGR) of 10.7 percent during the forecast period.1 One of the main drivers of the vaccine market is the need for greater supplies of vaccines, given stricter government […]
GlaxoSmithKline Partners with Viome to Develop New Vaccines
Vaccine manufacturer GlaxoSmithKline (GSK) of the United Kingdom has partnered with Viome, a gut microbiome test company in Seattle, Washington to better understand bacteria that live in the digestive tract and the role they play in the body’s immune system response.1 According to Emmanuel Hanon, senior vice president for research and development at GSK Vaccines, […]
Medical Errors Kill Five People Per Minute, 2.6 Million People Every Year
A new report published by the World Health Organization (WHO) estimates that 2.6 million people die annually in low-and middle-income countries from medical errors, and that most of those deaths are related to misdiagnosis and administration of pharmaceutical products. According to the WHO, “Four out of every ten patients are harmed during primary and ambulatory […]
CDC Urged to Be Truthful About Its Corporate Financial Ties
Public interest nonprofit organizations U.S. Right to Know and Public Citizen have petitioned the Centers for Disease Control and Prevention (CDC) to stop issuing false disclaimers that it “does not accept commercial support” and has “no financial interests or other relationships with the manufacturers of commercial products.”1 The CDC consistently publishes the following disclaimer throughout […]